Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01081340 · ClinicalTrials.gov registry record · NA

Building Social Networks to Enhance Postpartum Weight Loss and Appropriate Infant Feeding Practices

A NA study, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
NA
Development phase
41
Enrollment target

NCT01081340: Completed NA study, sponsored by Wake Forest University Health Sciences.

NCT01081340 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01081340, a NA study, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target

Study Summary

The purpose of this study is to examine whether we can use social networks to spread health information and health behaviors that 1) support women in returning to their pre-pregnancy weight after delivery; and 2) promote healthy infant feeding practices.

Primary Outcome

gestational weight gain and postpartum weight loss

Interventions

  • BEHAVIORAL Social network building intervention
  • BEHAVIORAL Home visit

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2010-05
Est. Completion 2011-08
Phase NA
Wake Forest University Health Sciences

1,140 total trials

What the finished NCT01081340 record still lists

NCT01081340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Social network building intervention is the first listed.

NCT01081340 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01081340 about?

NCT01081340 is a clinical study titled "Building Social Networks to Enhance Postpartum Weight Loss and Appropriate Infant Feeding Practices". The purpose of this study is to examine whether we can use social networks to spread health information and health behaviors that 1) support women in returning to their pre-pregnancy weight after delivery; and 2) promote healthy infant feeding practices.

What is the current status of trial NCT01081340?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2010-05. Estimated completion is 2011-08.

What interventions are being tested in trial NCT01081340?

The interventions under investigation include: Social network building intervention (BEHAVIORAL), Home visit (BEHAVIORAL).

Who is sponsoring clinical trial NCT01081340?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01081340's enrollment target sits among peer trials

41 1446th of 2000 higher than 554 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03449238 · 41 participants · Phase 1

    Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients

  • NCT03900793 · 41 participants · Phase 1

    Losartan + Sunitinib in Treatment of Osteosarcoma

  • NCT04082520 · 41 participants · Phase 2

    Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

  • NCT04220190 · 41 participants · Phase 2

    RAPA-501 Therapy for ALS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01081340, the US trial registry maintained by the National Library of Medicine. NCT01081340 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.